Expanding Treatment Options for HER2+ Breast Cancer | OncLive
OncLive SOSS

Expanding Treatment Options for HER2+ Breast Cancer

June 30, 2020
Adam Brufsky, MD, PhD, UPMC Hillman Cancer Center , Carey K. Anders, MD, Duke Cancer Institute , Virginia Kaklamani, MD, University of Texas Health Science Center , Rashmi K. Murthy, MD, MBE, MD Anderson Cancer Center , Mark D. Pegram, MD, Stanford Cancer Center



x